Skip to main content
. 2017 Nov 30;17:159. doi: 10.1186/s12871-017-0452-x
DKP/TRAM(N = 152) DKP (N = 151) TRAM (N = 150) Placebo (N = 153)
TOTPAR2 Responder, n (%) 91 (60) 69 (46) 58 (39) 50 (33)
Non-Responder, n (%) 60 (40) 82 (54) 91 (61) 103 (67)
Treatment comparisons p-value
DKP/TRAM vs. DKP 0.011
DKP/TRAM vs. TRAM <0.001
DKP vs. Placebo 0.020
TRAM vs. Placebo 0.258
TOTPAR4 Responder, n (%) 99 (65) 80 (53) 65 (43) 49 (32)
Non-Responder, n (%) 52 (34) 71 (47) 84 (56) 104 (68)
Treatment comparisons p-value
DKP/TRAM vs. DKP 0.026
DKP/TRAM vs. TRAM <0.001
DKP vs. Placebo <0.001
TRAM vs. Placebo 0.038
TOTPAR6 Responder, n (%) 105 (69) 72 (48) 64 (43) 49 (32)
Non-Responder, n (%) 46 (30) 79 (52) 85 (57) 104 (68)
Treatment comparisons p-value
DKP/TRAM vs. DKP <0.001
DKP/TRAM vs. TRAM <0.001
DKP vs. Placebo 0.005
TRAM vs. Placebo 0.050
TOTPAR8 Responder, n (%) 100 (66) 72 (48) 66 (44) 47 (31)
Non-Responder, n (%) 51 (34) 79 (52) 83 (55) 106 (69)
Treatment comparisons p-value
DKP/TRAM vs. DKP 0.001
DKP/TRAM vs. TRAM <0.001
DKP vs. Placebo 0.002
TRAM vs. Placebo 0.015